I’ve nailed a few of them lately. Today it’s DVAX, which has been a perpetual watch list item since taking a good profit on it in late 2019. Per the Trade Log:
5.28.20: I think the casino patrons that bought DVAX on the COVID vaccine hype have been punished enough as the stock pulls all the way back to the just now up-turning SMA 200 and fills that gap. DVAX is and has been about commercialization success (still a work in progress) of its Hepatitis vaccine, not some COVID-19 lottery ticket. Added it.
Of course we shall not speak of ZS, which is a stock I’ve traded and done well with for months now because it is in the right niche and it is a company that is performing. Unfortunately, it’s stock is performing now without me even though it’s the only item on my watch list that is circled, which means it was a priority. I just did not get around to it in time and now I can’t get around to it. Ah, the market.
Subscribe to NFTRH Premium (monthly at USD $35.00 or a discounted yearly at USD $365.00) for an in-depth weekly market report, interim market updates and NFTRH+ chart and trade setup ideas. You can also keep up to date with actionable public content at NFTRH.com by using the email form on the right sidebar. Follow via Twitter @NFTRHgt.
